JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
SPNT
SiriusPoint Ltd.
SPNT has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
SPNT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
SPNT's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like SPNT.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over SPNT in the historical PE scenario, which offers more potential upside but is not a forecast.
SPNT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.5x | $14.23 | -47% |
| Current | 6.6x | $26.81 | — |
| Fair | 7.8x | $31.56 | +18% |
| Forward | 9.9x | $26.81 | — |
| Expensive | 19x | $78.26 | +192% |
Historical ranges are pointers, not guarantees.
SPNT's PE is in its fair range at 6.6x. On analysts' estimates for next year's earnings, today's price would be 9.9x.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over SPNT on the outlook, with more favorable valuation and revenue expectations.
SPNT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect SPNT's earnings to grow, with its revenue and profitability holding steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
SPNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.72 | -33% |
| Q3 2026 | $4.06 | +143% |
| Q2 2026 | $4.05 | +318% |
| Q1 2026 | $3.97 | +282% |
| Q4 2025 | $3.64 | +250% |
| Q3 2025 | $1.67 | +6.4% |
| Q2 2025 | $0.97 | -48% |
| Q1 2025 | $1.04 | -37% |
| Q4 2024 | $1.04 | -47% |
SPNT earned $4.06 per share over the past year, up 143% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over SPNT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over SPNT on profitability, with a higher operating margin.
SPNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $867.6M | +15% |
| Q2 2026 | $744.1M | -0.5% |
| Q1 2026 | $774.6M | +6.5% |
| Q4 2025 | $973.7M | +59% |
| Q3 2025 | $755.9M | +34% |
| Q2 2025 | $748.2M | +0.7% |
| Q1 2025 | $727.3M | +6.1% |
| Q4 2024 | $612.8M | -5.1% |
SPNT's revenue has picked up after two years of holding roughly level: $868M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -2.7 points |
| Q2 2026 | 11% | +1.3 points |
| Q1 2026 | 16% | +5.3 points |
| Q4 2025 | 29% | +31 points |
| Q3 2025 | 15% | +13 points |
| Q2 2025 | 10% | -7.3 points |
| Q1 2025 | 10% | -5.1 points |
| Q4 2024 | -2.1% | -1.8 points |
SPNT's operating margin was 12% last quarter, down 2.7 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
SPNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $170M | +9.3% |
| Q2 2026 | -$5.2M | -108% |
| Q1 2026 | $141.9M | +$230.8M |
| Q4 2025 | -$26.4M | -125% |
| Q3 2025 | $155.6M | +168% |
| Q2 2025 | $62.1M | +$209M |
| Q1 2025 | -$88.9M | -259% |
| Q4 2024 | $107.7M | -50% |
SPNT has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over SPNT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
SPNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -1.8M shares |
| 1 year | -1.4% | -1.7M shares |
| 3 years | -30% | -51.3M shares |
| 5 years | -27% | -43.1M shares |
| Available history | +26% | +24.5M shares |
SPNT has 117M diluted shares, down 1.4% from a year ago, with $101M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $27.3M |
| Q2 2026 | $51.4M |
| Q1 2026 | $21.9M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $490.8M |
| Q4 2024 | $170M |
SPNT spent $101M buying back its own shares over the past year, down 85% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
SPNT Net Leverage
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
SPNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.5 | Neutral |
| Stochastic | 84.7 | Overbought |
SPNT's weekly RSI is 67 (neutral) and its Stochastic is 85 (overbought).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
SPNT PE vs Financial Services Sector
| Metric | SPNT | Sector median | Relative |
|---|---|---|---|
| PE | 6.6x | 13x | 49% below |
| PE % | 38 | 63 | 25 pts below |
SPNT has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
SPNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.6 | 4.8% above |
| 20 week MA | $24.8 | 8.1% above |
| 50 week MA | $23.0 | 17% above |
| 100 week MA | $20.3 | 32% above |
| 200 week MA | $15.8 | 70% above |
SPNT has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
SPNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.5 | $9.26 | -12% |
| 2021 | $9.26 | $8.25 | -11% |
| 2022 | $8.25 | $6.25 | -24% |
| 2023 | $6.25 | $11.6 | +86% |
| 2024 | $11.6 | $14.2 | +23% |
| 2025 | $14.2 | $22.3 | +57% |
| 2026 YTD | $22.3 | $26.8 | +20% |
SPNT has the edge over JPM on returns for 2026, with the stronger performance.